Acorda Therapeutics reported $184.98M in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 184.98M 2.54M
Agios Pharmaceuticals AGIO:US $ 1.06M 0.78M
ALKERMES ALKS:US 291.54M 634K
Amgen AMGN:US $ 35705M 305M
Aptinyx Inc APTX:US $ 24.5M 206K
Arrowhead Research ARWR:US $ 0 0
Biogen BIIB:US $ 6277.4M 1.7M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Cara Therapeutics CARA:US $ 0 0
Clovis Oncology CLVS:US $ 621.38M 7.38M
Cytokinetics CYTK:US $ 198.42M 1.34M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
GlaxoSmithKline GSK:LN 1878400M 1044200M
Halozyme Therapeutics HALO:US $ 1147.13M 359.03M
Insmed INSM:US $ 807.11M 447K
Mannkind MNKD:US $ 366.99M 8.14M
Merck MRK:GR € 9385M 1099M
Moderna Inc MRNA:US $ 641M 5M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Novartis NOVN:VX SF 23784M 589M
Teva Pharmaceutical TEVA:IT 20.36B 477M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M